1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. CXO Perspective
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. LARGE VOLUME PARENTERAL MARKET BY VOLUME
5.1. Introduction
5.2. 100 ml - 250 ml
5.3. 250 ml - 500 ml
5.4. Above 500 ml
6. LARGE VOLUME PARENTERAL MARKET BY APPLICATION
6.1. Introduction
6.2. Correction of electrolyte & fluid balance disturbances
6.3. Nutrition
6.4. Vehicle for administering other drugs
7. LARGE VOLUME PARENTERAL MARKET BY PACKAGING CONTAINER
7.1. Introduction
7.2. Correction of electrolyte & fluid balance disturbances
7.3. Nutrition
7.4. Vehicle for administering other drugs
8. LARGE VOLUME PARENTERAL MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Volume
8.2.2. By Application
8.2.3. By Packaging Container
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Volume
8.3.2. By Application
8.3.3. By Packaging Container
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Volume
8.4.2. By Application
8.4.3. By Packaging Container
8.4.4. By Country
8.4.4.1. UK
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Italy
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Volume
8.5.2. By Application
8.5.3. By Packaging Container
8.5.4. By Country
8.5.4.1. UAE
8.5.4.2. Israel
8.5.4.3. Saudi Arabia
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Volume
8.6.2. By Application
8.6.3. By Packaging Container
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Thailand
8.6.4.7. Indonesia
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Fresenius Kabi AG
10.2. Albert David Ltd.
10.3. Otsuka Holdings Co., Ltd.
10.4. Grifols S.A.
10.5. B. Braun Melsungen AG
10.6. BML Parenteral Drugs
10.7. Akums Drugs & Pharmaceuticals Ltd.
10.8. DJ Labs
10.9. Parenteral Drugs (India) Limited
10.10. BKRS Pharma Pvt. Ltd.
10.11. Pfizer.
10.12. Baxter.
10.13. August Services
10.14. INCOG BioPharma Services
10.15. Simtra BioPharma Solutions